Mutant p53 tumor suppressor alleles release ras-induced cell cycle growth arrest.
- 1 March 1991
- journal article
- research article
- Published by Taylor & Francis in Molecular and Cellular Biology
- Vol. 11 (3) , 1344-1352
- https://doi.org/10.1128/mcb.11.3.1344
Abstract
Overexpression of an activated ras gene in the rat embryo fibroblast line REF52 results in growth arrest at either the G1/S or G2/M boundary of the cell cycle. Both the DNA tumor virus proteins simian virus 40 large T antigen and adenovirus 5 E1a are able to rescue ras induced lethality and cooperate with ras to fully transform REF52 cells. In this report, we present evidence that the wild-type activity of the tumor suppressor gene p53 is involved in the negative growth regulation of this model system. p53 genes encoding either a p53Val-135 or p53Pro-193 mutation express a highly stable p53 protein with a conformation-dependent loss of wild-type activity and the ability to eliminate any endogenous wild-type p53 activity in a dominant negative manner. In cotransfection assays, these mutant p53 genes are able to rescue REF52 cells from ras-induced growth arrest, resulting in established cell lines which express elevated levels of the ras oncoprotein and show morphological transformation. Full transformation, as assayed by tumor formation in nude mice, is found only in the p53Pro-193-plus-ras transfectants. These cells express higher levels of the ras protein than do the p53Val-135-plus-ras-transfected cells. Transfection of REF52 cells with ras alone or a full-length genomic wild-type p53 plus ras results in growth arrest and lethality. Therefore, the selective event for p53 inactivation or loss during tumor progression may be to overcome a cell cycle restriction induced by oncogene overexpression (ras). These results suggest that a normal function of p53 may be to mediate negative growth regulation in response to ras or other proliferative inducing signals.Keywords
This publication has 52 references indexed in Scilit:
- Tumor suppressor genes: the p53 and retinoblastoma sensitivity genes and gene productsBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1990
- Genetic changes in skin tumor progression: Correlation between presence of a mutant ras gene and loss of heterozygosity on mouse chromosome 7Cell, 1990
- Mutations in the p53 gene occur in diverse human tumour typesNature, 1989
- Chromosome 17 Deletions and p53 Gene Mutations in Colorectal CarcinomasScience, 1989
- Activated N-ras controls the transformed phenotype of HT1080 human fibrosarcoma cellsCell, 1987
- ras GENESAnnual Review of Biochemistry, 1987
- Replacement of insulin receptor tyrosine residues 1162 and 1163 compromises insulin-stimulated kinase activity and uptake of 2-deoxyglucoseCell, 1986
- In vitro establishment is not a sufficient prerequisite for transformation by activated ras oncogenesCell, 1986
- Adenovirus early region 1A enables viral and cellular transforming genes to transform primary cells in cultureNature, 1983
- Isolation of a transforming sequence from a human bladder carcinoma cell lineCell, 1982